Open-Label Randomized Trial of Early Clinical Outcomes of Ceftaroline Fosamil Versus Vancomycin for the Treatment of Acute Bacterial Skin and Skin Structure Infections at Risk of Methicillin-Resistant Staphylococcus aureus
Publication Date
3-27-2019
DOI
10.1007/s40121-019-0242-5
ISSN
2193-6382
Publication Title
Infectious Diseases and Therapy
Recommended Citation
Claeys, K. C., Zasowski, E. J., Trinh, T. D., Casapao, A. M., Pogue, J. M., Bhatia, N., Mynatt, R. P., Wilson, S. S., Arthur, C., Welch, R., Sherwin, R., Hafeez, W., Levine, D. P., Kaye, K. S., Delgado, G., Giuliano, C. A., Takla, R., Rieck, C., Johnson, L. B., … Rybak, M. J. (2019). Open-Label Randomized Trial of Early Clinical Outcomes of Ceftaroline Fosamil Versus Vancomycin for the Treatment of Acute Bacterial Skin and Skin Structure Infections at Risk of Methicillin-Resistant Staphylococcus aureus. Infectious Diseases and Therapy, 8(2), 199–208. https://doi.org/10.1007/s40121-019-0242-5
Comments
See the work itself for complete list of authors. See here.